Clusterin expression in cutaneous CD30-positive lymphoproliferative disorders and their histologic simulants

Journal of Cutaneous Pathology

Volumn 36, Issue 3, 2009, Pages 302-307

  Olsen, Stephen H ^a   Ma, Linglei ^a   Schnitzer, Bertram ^a   Fullen, Douglas R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; FORMALDEHYDE; PARAFFIN;

ARTICLE; CD30+ T LYMPHOCYTE; CELL TRANSFORMATION; CYTOPLASM; DENDRITIC CELL; GOLGI COMPLEX; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSECT BITE; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS FUNGOIDES; PITYRIASIS LICHENOIDES; PROTEIN EXPRESSION; PSEUDOLYMPHOMA; SKIN MANIFESTATION; STAINING; T LYMPHOCYTE; TISSUE SECTION;

ANTIGENS, CD30; CLUSTERIN; DENDRITIC CELLS; DERMIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GOLGI APPARATUS; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; NEOPLASM PROTEINS;

EID: 59149104577     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01036.x     Document Type: Article

References (19)

1. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002 34 : 427.
2. Rosenberg ME, Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995 27 : 633.
3. Wellman A, Thieblemont C, Pittaluga S, et al. Detection of differently expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large cell-lymphomas. Blood 2000 96 : 398.
4. Saffer H, Wahed A, Rassidakis GZ, Medeiros LJ. Clusterin expression in malignant lymphomas: a survey of 266 cases. Mod Pathol 2002 15 : 1221.
5. Lae ME, Ahmed I, Macon WR. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. Am J Clin Pathol 2002 118 : 773.
6. Nascimento AF, Pinkus JL, Pinkus GS. Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms. Am J Clin Pathol 2004 121 : 709.
7. Su LD, Duncan LM. Lymphoma and leukemia-associated cutaneous atypical CD30+ T-cell reactions. J Cutan Pathol 2000 27 : 249.
8. Willemze R, Meijer CJ. Primary cutaneous CD30-positive lymphoproliferative disorders. Hematol Oncol Clin N Am 2003 17 : 1319.
9. Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulants. J Cutan Pathol 2006 33 (Suppl. 1 58.
10. Kadin ME. Pathobiology of CD30+ cutaneous T-cell lymphomas. J Cutan Pathol 2006 33 (Suppl. 1 10.
11. El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004 140 : 441.
12. Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas. Semin Hematol 2003 40 : 244.
13. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768.
14. Vergier B, deMuret A, Beylot-Barry M, et al. Transformation of mycosis fungoides: clinicopathologic and prognostic features from 45 cases. Blood 2000 95 : 2212.
15. Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood 1998 92 : 1150.
16. Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias. Semin Cutan Med Surg 2000 19 : 133.
17. Cepeda LT, Pieretti M, Chapman SF, Horenstein MG. CD30-positive atypical lymphoid cells in common non-neoplastic cutaneous infiltrates rich in neutrophils and eosinophils. Am J Surg Pathol 2003 27 : 912.
18. Grogg KL, Macon WR, Kurtin PJ, Nascimento AG. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol 2005 18 : 260.
19. Grogg KL, Lae ME, Kurtin PJ, Macon WR. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 2004 28 : 988.